Emerging Therapies for Eosinophilic Gastrointestinal Diseases.

Peterson, Kathryn; Safroneeva, Ekaterina; Schoepfer, Alain (2021). Emerging Therapies for Eosinophilic Gastrointestinal Diseases. Journal of allergy and clinical immunology. In practice, 9(9), pp. 3276-3281. Elsevier 10.1016/j.jaip.2021.07.031

Preview	Text Peterson_JAllergyClinImmunolPract_AAM.pdf - Accepted Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (1MB) | Preview
	Text Peterson_JAllergyClinImmunolPract_2021.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (237kB)

Besides eosinophilic esophagitis, other eosinophilic gastrointestinal diseases (EGIDs), such as eosinophilic gastritis, eosinophilic gastroenteritis, and eosinophilic colitis, are increasingly diagnosed over the last decade. Whereas diagnosis and therapy of eosinophilic esophagitis have been standardized, the diagnosis and therapy of other EGIDs are areas of active research. Motivated by the increasing prevalence of these conditions, concerted efforts of different stakeholders have led to the evaluation of targeted biologic therapies for EGID management over the last couple of years, and several promising molecules are currently in the pipeline. This review article provides an overview of targeted biologic therapies for use in EGIDs.

Interest & Impact

Downloads

261 since deposited on 12 Aug 2021
91 in the past 12 months

Citations

5 Citations in Web of Science ®
6 Citations in Scopus

Search

in Google Scholar™

Services

Actions (login required)

Edit item

Actions (login required)

Edit item